Gold tier: mechanically validated evidence, with its primary source.
134 evidence items · page 4 / 6
1.37 adjusted_odds_ratioHigher parity was independently associated with HBV infection in pregnancy, with an adjusted odds ratio of 1.37.
Nigeriahépatite Bobserved November 1, 2017 to April 30, 2018published 2020Annals of African medicinePubMeddocument of 5 observations
3.3 %The prevalence of hepatitis B surface antigen (HBsAg) in the study population was 3.3%.
Nigeriahépatite Bpublished 2025American journal of clinical pathologyPubMeddocument of 5 observations
5.3 %The prevalence of HBV infection using HBsAg was 5.3% among HIV-infected children in Lagos.
Nigeriahépatite B · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
23.3 %The prevalence of hepatitis B surface antigen (HBsAg) among patients attending public hospitals in Lagos, Nigeria was 23.3%.
Nigeriahépatite Bpublished 2025The Nigerian postgraduate medical journalPubMeddocument of 7 observations
9.3 %Drug-resistant associated HBV variants were detected in 9.3% of cases.
Nigeriahépatite Bobserved 2018published 2025Pathogens (Basel, Switzerland)PubMeddocument of 8 observations
0 %The mother-to-child transmission (MTCT) rate for HIV, HBV, and HCV among pregnant women in Nigeria was 0% at 6-week post-delivery.
Nigeriahépatite B · hépatite C · VIH/sidaobserved 6-week post-deliverypublished 2025Antiviral therapyPubMeddocument of 7 observations
8 %Among all donors tested for transfusion transmissible infections, 761 (8.0%) tested positive for Hepatitis B.
Nigeriahépatite Bobserved 2020-2022published 2025BMC infectious diseasesPubMeddocument of 17 observations
1.6 %HBV genotype A was found in 1.6% of cases in Nigeria.
Nigeriahépatite Bobserved 2018published 2025Pathogens (Basel, Switzerland)PubMeddocument of 8 observations
9.93 fLMean platelet volume (MPV) of 9.93 ± 1.1 fL in SCD individuals with HBV was significantly higher than 8.30 ± 0.95 fL in SCD individuals without HBV.
Nigeriahépatite Bpublished 2021West African journal of medicineeurope_pmcdocument of 4 observations
20 casesAmong 250 patients with HIV/AIDS screened for HBV, 20 (8%) were identified as HBV-infected.
Nigeriahépatite B · VIH/sidapublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 11 observations
7.63 %The overall hepatitis B positivity rate in Nigeria was 7.63%.
Nigeriahépatite Bobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations
1.92 adjusted_odds_ratioAge was significantly associated with HBV vaccination completion, with an adjusted odds ratio of 1.92 (95% CI: 1.23, 3.03) in Lagos state, Nigeria.
Nigeriahépatite Bobserved June 2021 to June 2024published 2026PloS onePubMeddocument of 12 observations
10 %The prevalence of anti-HBs among 150 PLHIV in the study was 10%.
Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations
17.7 %Among PLHIV aged 51–60 years, the prevalence of HBsAg was 17.7%.
Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations
58.4 %The HBV vaccination completion rate was 58.4% among participants aged 30–34 years in Lagos state, Nigeria.
Nigeriahépatite Bobserved June 2021 to June 2024published 2026PloS onePubMeddocument of 12 observations
10.9 %HBV prevalence among study participants was 10.9%.
Nigeriahépatite Bobserved 2009-12published 2016PloS onePubMeddocument of 14 observations
81.3 %One hundred and twenty-two (81.3%) of 150 PLHIV tested negative to all hepatitis B virus markers.
Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations
6 %The prevalence of Hepatitis B co-infection among people living with HIV/AIDS in a rural Northern Nigerian community was 6.0%.
Nigeriahépatite B · VIH/sidapublished 2020The Pan African medical journalPubMeddocument of 4 observations
45.4 %The overall HBV vaccination completion rate was 45.4% among 641 study participants in Lagos state, Nigeria.
Nigeriahépatite Bobserved June 2021 to June 2024published 2026PloS onePubMeddocument of 12 observations
1.3 %In 2019, the hepatitis B virus (HBV) positivity rate among screened pregnant women in the South East zone of Nigeria was 1.3%.
Nigeriahépatite Bobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 10 observations
2.5 %In 2019, the hepatitis B virus (HBV) screening rate among pregnant women in the North East zone of Nigeria was 2.5%.
Nigeriahépatite Bobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 10 observations
22.2 %A high prevalence of 22.2% (6 out of 27) of HBV resistance mutations was detected among ART-experienced HBV-HIV-coinfected patients in southwestern Nigeria.
Nigeriahépatite B · VIH/sidapublished 2019Antiviral therapyPubMeddocument of 4 observations
57.4 %57.4% of subjects were infected with chronic HBV (HBsAg+).
Nigeriacarcinome hépatocellulaire · hépatite Bpublished 2021Tropical medicine & international health : TM & IHPubMeddocument of 15 observations
2,700,000 peopleGlobally, approximately 2.7 million people living with HIV are co-infected with hepatitis B virus.
Nigeriahépatite B · VIH/sidapublished 2024Journal of infection in developing countriesPubMeddocument of 5 observations
1.8 %Among female PLHIV participants, the prevalence of anti-HBs was 1.8%.
Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.